MARSHA L SEIBERT

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family FRANKLINTON, LA NPI 1396239869

General Payments — all program years on this page

$5,118.29

  • Category: General Payments
  • Program years: PY2021–2024
  • Record count: 86
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $1,215.10 across 12 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $1,215.1012

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Acerta Pharma LLC $464.324
Gilead Sciences, Inc. $226.543
ABBVIE INC. $119.231
Novo Nordisk AS $106.821
Neurelis, Inc. $101.001
Phathom Pharmaceuticals, Inc. $100.001
NOVARTIS PHARMACEUTICALS CORPORATION $97.191

By program year

Program yearAmountRecords
2021 $567.035
2022 $1,118.9824
2023 $2,217.1845
2024 $1,215.1012

Records — PY2024 (12)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1087345285 Novartis Pharmaceuticals Corporation $97.19 12/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100501389 Novo Nordisk Inc $106.82 06/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1108171000 ABBVIE INC. $119.23 09/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1123302608 AstraZeneca Pharmaceuticals LP $119.35 02/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1123304308 AstraZeneca Pharmaceuticals LP $114.99 05/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1123307320 AstraZeneca Pharmaceuticals LP $114.99 09/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1123310280 AstraZeneca Pharmaceuticals LP $114.99 01/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133706304 Gilead Sciences, Inc. $115.00 05/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133706306 Gilead Sciences, Inc. $55.77 08/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133706308 Gilead Sciences, Inc. $55.77 08/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145670432 Neurelis, Inc. $101.00 03/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151204283 Phathom Pharmaceuticals, Inc. $100.00 08/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.